vs
Side-by-side financial comparison of FRANKLIN STREET PROPERTIES CORP (FSP) and GYRE THERAPEUTICS, INC. (GYRE). Click either name above to swap in a different company.
GYRE THERAPEUTICS, INC. is the larger business by last-quarter revenue ($37.2M vs $26.0M, roughly 1.4× FRANKLIN STREET PROPERTIES CORP). GYRE THERAPEUTICS, INC. runs the higher net margin — -3.7% vs -28.1%, a 24.4% gap on every dollar of revenue. On growth, GYRE THERAPEUTICS, INC. posted the faster year-over-year revenue change (33.4% vs -8.2%). GYRE THERAPEUTICS, INC. produced more free cash flow last quarter ($-5.8M vs $-12.7M). Over the past eight quarters, GYRE THERAPEUTICS, INC.'s revenue compounded faster (17.0% CAGR vs -8.7%).
Franklin Street Properties Corp is a Massachusetts-based real estate investment trust (REIT) in the United States. It primarily invests in, owns, and operates high-quality office properties across major U.S. metropolitan markets, serving corporate tenants across various industry segments, and delivers stable long-term returns via rental income and strategic asset management.
GYRE Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel targeted therapies for hard-to-treat hematologic malignancies and solid tumors. It focuses on precision oncology to address unmet patient needs, with operations primarily based in North America.
FSP vs GYRE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $26.0M | $37.2M |
| Net Profit | $-7.3M | $-1.4M |
| Gross Margin | 59.4% | 95.3% |
| Operating Margin | -27.9% | 0.3% |
| Net Margin | -28.1% | -3.7% |
| Revenue YoY | -8.2% | 33.4% |
| Net Profit YoY | 14.1% | -340.1% |
| EPS (diluted) | $-0.06 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.0M | $37.2M | ||
| Q3 25 | $27.3M | $30.6M | ||
| Q2 25 | $26.7M | $26.8M | ||
| Q1 25 | $27.1M | $22.1M | ||
| Q4 24 | $28.4M | $27.9M | ||
| Q3 24 | $29.7M | $25.5M | ||
| Q2 24 | $30.8M | $25.2M | ||
| Q1 24 | $31.2M | $27.2M |
| Q4 25 | $-7.3M | $-1.4M | ||
| Q3 25 | $-8.3M | $5.9M | ||
| Q2 25 | $-7.9M | $1.6M | ||
| Q1 25 | $-21.4M | $3.7M | ||
| Q4 24 | $-8.5M | $569.0K | ||
| Q3 24 | $-15.6M | $2.9M | ||
| Q2 24 | $-21.0M | $4.5M | ||
| Q1 24 | $-7.6M | $9.9M |
| Q4 25 | 59.4% | 95.3% | ||
| Q3 25 | 60.9% | 94.7% | ||
| Q2 25 | 59.9% | 95.7% | ||
| Q1 25 | 62.8% | 95.9% | ||
| Q4 24 | 59.7% | 95.8% | ||
| Q3 24 | 61.0% | 96.2% | ||
| Q2 24 | 64.2% | 96.9% | ||
| Q1 24 | 64.7% | 96.4% |
| Q4 25 | -27.9% | 0.3% | ||
| Q3 25 | -30.5% | 22.7% | ||
| Q2 25 | -29.2% | 8.1% | ||
| Q1 25 | -78.9% | 10.3% | ||
| Q4 24 | -29.9% | 2.4% | ||
| Q3 24 | -52.4% | 16.6% | ||
| Q2 24 | -68.0% | 12.7% | ||
| Q1 24 | -24.0% | 29.7% |
| Q4 25 | -28.1% | -3.7% | ||
| Q3 25 | -30.5% | 19.4% | ||
| Q2 25 | -29.5% | 5.9% | ||
| Q1 25 | -79.1% | 16.9% | ||
| Q4 24 | -30.0% | 2.0% | ||
| Q3 24 | -52.6% | 11.2% | ||
| Q2 24 | -68.2% | 18.0% | ||
| Q1 24 | -24.2% | 36.6% |
| Q4 25 | $-0.06 | $-0.01 | ||
| Q3 25 | $-0.08 | $0.03 | ||
| Q2 25 | $-0.08 | $0.00 | ||
| Q1 25 | $-0.21 | $0.00 | ||
| Q4 24 | $-0.09 | $0.00 | ||
| Q3 24 | $-0.15 | $0.01 | ||
| Q2 24 | $-0.20 | $0.01 | ||
| Q1 24 | $-0.07 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $30.6M | $52.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $607.0M | $106.0M |
| Total Assets | $892.9M | $166.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $30.6M | $52.4M | ||
| Q3 25 | $31.4M | $60.0M | ||
| Q2 25 | $29.4M | $54.4M | ||
| Q1 25 | $30.2M | $29.9M | ||
| Q4 24 | $41.1M | $26.7M | ||
| Q3 24 | $40.9M | $25.1M | ||
| Q2 24 | $30.2M | $25.1M | ||
| Q1 24 | $34.2M | $37.4M |
| Q4 25 | $607.0M | $106.0M | ||
| Q3 25 | $615.3M | $101.9M | ||
| Q2 25 | $624.7M | $92.0M | ||
| Q1 25 | $633.4M | $68.1M | ||
| Q4 24 | $655.9M | $63.3M | ||
| Q3 24 | $665.4M | $63.2M | ||
| Q2 24 | $682.1M | $60.4M | ||
| Q1 24 | $703.9M | $56.6M |
| Q4 25 | $892.9M | $166.1M | ||
| Q3 25 | $901.0M | $159.4M | ||
| Q2 25 | $903.2M | $152.6M | ||
| Q1 25 | $916.4M | $129.8M | ||
| Q4 24 | $946.9M | $125.4M | ||
| Q3 24 | $981.5M | $125.2M | ||
| Q2 24 | $1.0B | $120.9M | ||
| Q1 24 | $1.0B | $122.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.8M | $-5.6M |
| Free Cash FlowOCF − Capex | $-12.7M | $-5.8M |
| FCF MarginFCF / Revenue | -48.6% | -15.5% |
| Capex IntensityCapex / Revenue | 63.0% | 0.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-25.3M | $-180.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.8M | $-5.6M | ||
| Q3 25 | $8.3M | $4.7M | ||
| Q2 25 | $-2.9M | $2.1M | ||
| Q1 25 | $-5.5M | $-129.0K | ||
| Q4 24 | $9.0M | $-2.8M | ||
| Q3 24 | $14.5M | $1.7M | ||
| Q2 24 | $-648.0K | $-5.5M | ||
| Q1 24 | $-7.1M | $2.9M |
| Q4 25 | $-12.7M | $-5.8M | ||
| Q3 25 | $3.0M | $4.0M | ||
| Q2 25 | $-5.7M | $1.8M | ||
| Q1 25 | $-9.9M | $-251.0K | ||
| Q4 24 | $-16.2M | $-2.8M | ||
| Q3 24 | $8.6M | $1.0M | ||
| Q2 24 | $-5.1M | $-6.9M | ||
| Q1 24 | $-15.8M | $2.7M |
| Q4 25 | -48.6% | -15.5% | ||
| Q3 25 | 11.0% | 13.1% | ||
| Q2 25 | -21.5% | 6.8% | ||
| Q1 25 | -36.7% | -1.1% | ||
| Q4 24 | -57.2% | -10.1% | ||
| Q3 24 | 29.1% | 4.1% | ||
| Q2 24 | -16.7% | -27.5% | ||
| Q1 24 | -50.8% | 9.8% |
| Q4 25 | 63.0% | 0.4% | ||
| Q3 25 | 19.4% | 2.2% | ||
| Q2 25 | 10.7% | 1.0% | ||
| Q1 25 | 16.4% | 0.6% | ||
| Q4 24 | 88.9% | 0.2% | ||
| Q3 24 | 19.6% | 2.7% | ||
| Q2 24 | 14.6% | 5.8% | ||
| Q1 24 | 28.1% | 0.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.79× | ||
| Q2 25 | — | 1.32× | ||
| Q1 25 | — | -0.03× | ||
| Q4 24 | — | -4.85× | ||
| Q3 24 | — | 0.60× | ||
| Q2 24 | — | -1.21× | ||
| Q1 24 | — | 0.29× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
